Indication
Acute Staph. aureus sinusitis
Acute *Staph. Read more about Acute Staph. aureus sinusitis
136 drugs 82 manufacturers
Drugs that treat it
Common Acute Staph. aureus sinusitis therapies.
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute *Staph.
aureus* sinusitis is an acute bacterial infection of the paranasal sinus mucosa caused specifically by *Staphylococcus aureus*.
It primarily affects the respiratory system in pediatric and adult populations, often arising following ostiomeatal obstruction, viral upper respiratory illness, or nosocomial predisposing factors.
Pathophysiologically, localized mucosal inflammation and impaired mucociliary clearance facilitate colonization, mucosal invasion, and suppurative inflammation driven by staphylococcal virulence factors and toxins.
Clinically, it is characterized by symptoms lasting under four weeks, including purulent rhinorrhea, nasal congestion, facial pain or pressure, and fever, with an elevated potential for invasive local complications or treatment challenges associated with antibiotic-resistant strains.
- fda.gov
Acute *Staph. aureus* sinusitis is an acute bacterial infection of the paranasal sinus mucosa caused specifically by *Staphylococcus aureus*
- nih.gov
Acute *Staph. aureus* sinusitis is an acute bacterial infection of the paranasal sinus mucosa caused specifically by *Staphylococcus aureus* It primarily affects the respiratory system in pediatric and adult populations, often arising following ostiomeatal obstruction, viral upper respiratory illness, or nosocomial predisposing factors Clinically, it is characterized by symptoms lasting under four weeks, including purulent rhinorrhea, nasal congestion, facial pain or pressure, and fever, with an...
- nih.gov
It primarily affects the respiratory system in pediatric and adult populations, often arising following ostiomeatal obstruction, viral upper respiratory illness, or nosocomial predisposing factors
- nih.gov
It primarily affects the respiratory system in pediatric and adult populations, often arising following ostiomeatal obstruction, viral upper respiratory illness, or nosocomial predisposing factors Pathophysiologically, localized mucosal inflammation and impaired mucociliary clearance facilitate colonization, mucosal invasion, and suppurative inflammation driven by staphylococcal virulence factors and toxins Clinically, it is characterized by symptoms lasting under four weeks, including purulent ...
- nih.gov
Pathophysiologically, localized mucosal inflammation and impaired mucociliary clearance facilitate colonization, mucosal invasion, and suppurative inflammation driven by staphylococcal virulence factors and toxins
- aafp.org
Clinically, it is characterized by symptoms lasting under four weeks, including purulent rhinorrhea, nasal congestion, facial pain or pressure, and fever
- nih.gov
Clinically, it is characterized by symptoms lasting under four weeks, including purulent rhinorrhea, nasal congestion, facial pain or pressure, and fever, with an elevated potential for invasive local complications or treatment challenges associated with antibiotic-resistant strains
Personalize your experience
Follow Acute Staph. aureus sinusitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.